Abstract
The individual searches for a natural antagonist of cortisol and for critical mediators of sepsis have converged in the finding that MIF is an important mediator of septic shock. The intersection of these two efforts reminds us that progress in scientific research often comes from surprising directions (164–170).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bloom, B.R. & Bennett, B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80–82 (1966).
David, J.R. Delayed hypersensitify in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56, 72–77 ( 1966).
Bernhagen, J. et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature 365, 756– 759 (1993).
Calandra, T. et al. MIF as a glucocorticoid-induced modulator of cytokine production . Nature 377, 68–71 (1995).
Weiser, W.Y. et al. Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA 86, 7522–7526 (1989).
Calandra, T. et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor (MIF). Nature Med. 6, 164–170 (2000).
Fowler, A.A. III, et al. Adult respiratory distress syndrome: risk with common predispositions . Ann. Intern. Med. 98, 593– 597 (1983).
Montgomery, A.B., Stager, M.A., Carrico, C.J. & Hudson, L.D. Causes of mortality in patients with the adult respiratory distress syndrome . Am. Rev. Respir. Dis. 132, 485– 489 (1985).
Abraham, E. Why immunomodulatory therapies have not worked in sepsis. Intensive Care Med. 25, 556–566 ( 1999).
Donnelly, S.C. et al. Regulatory role for macrophage migration inhibitory factor in the acute respiratory distress syndrome. Nature Med. 3, 320–323 (1997).
Bernard, G.R. et al. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149, 818– 824 (1994).
Hudson, L.D., Milberg, J.A., Anardi, D. & Maunder, R.J. Clinical risks for development of the acute respiratory distress syndrome . Am. J. Respir. Crit. Care Med. 151, 293 –301 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martin, T. MIF mediation of sepsis. Nat Med 6, 140–141 (2000). https://doi.org/10.1038/72230
Issue Date:
DOI: https://doi.org/10.1038/72230
This article is cited by
-
Association of the macrophage migration inhibitory factor −173*C allele with childhood nephrotic syndrome
Pediatric Nephrology (2008)
-
The vagus nerve and the nicotinic anti-inflammatory pathway
Nature Reviews Drug Discovery (2005)
-
Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis
Nature Medicine (2004)
